AU7871698A - Hepatitis delta particle containing a fusion protein immunogen - Google Patents

Hepatitis delta particle containing a fusion protein immunogen

Info

Publication number
AU7871698A
AU7871698A AU78716/98A AU7871698A AU7871698A AU 7871698 A AU7871698 A AU 7871698A AU 78716/98 A AU78716/98 A AU 78716/98A AU 7871698 A AU7871698 A AU 7871698A AU 7871698 A AU7871698 A AU 7871698A
Authority
AU
Australia
Prior art keywords
fusion protein
particle containing
hepatitis delta
protein immunogen
delta particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78716/98A
Inventor
Eric James Gowans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
State of Queensland Department of Health
Original Assignee
CROWN IN RIGHT OF QUEE
State of Queensland Department of Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO4341A external-priority patent/AUPO434196A0/en
Application filed by CROWN IN RIGHT OF QUEE, State of Queensland Department of Health filed Critical CROWN IN RIGHT OF QUEE
Priority to AU78716/98A priority Critical patent/AU7871698A/en
Publication of AU7871698A publication Critical patent/AU7871698A/en
Abandoned legal-status Critical Current

Links

AU78716/98A 1996-12-24 1997-12-24 Hepatitis delta particle containing a fusion protein immunogen Abandoned AU7871698A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78716/98A AU7871698A (en) 1996-12-24 1997-12-24 Hepatitis delta particle containing a fusion protein immunogen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPO4341A AUPO434196A0 (en) 1996-12-24 1996-12-24 An improved therapeutic
AUPO4341 1996-12-24
PCT/AU1997/000884 WO1998028004A1 (en) 1996-12-24 1997-12-24 Hepatitis delta particle containing a fusion protein immunogen
AU78716/98A AU7871698A (en) 1996-12-24 1997-12-24 Hepatitis delta particle containing a fusion protein immunogen

Publications (1)

Publication Number Publication Date
AU7871698A true AU7871698A (en) 1998-07-17

Family

ID=25638993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78716/98A Abandoned AU7871698A (en) 1996-12-24 1997-12-24 Hepatitis delta particle containing a fusion protein immunogen

Country Status (1)

Country Link
AU (1) AU7871698A (en)

Similar Documents

Publication Publication Date Title
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU6304996A (en) Vaccines against hepatitis c
AU5065198A (en) Fusion proteins having increased half-lives
AU3827695A (en) Antigen-binding fusion proteins
AU4878096A (en) Hepatitis b vaccine
AU2064297A (en) Hepatitis c virus ribozymes
AU3811495A (en) Antibodies
AU2842095A (en) High-zirconia fused refractories
EP0621130A3 (en) Solid phase bonding method
AU5681498A (en) A ctla4-ig fusion protein having high titer
AU6873596A (en) Allergen-xcd32 fusion proteins
AU2645297A (en) Hepatitis b monoclonal antibodies
AU9798398A (en) Gfp-annexin fusion proteins
AU3804397A (en) Hexameric fusion proteins and uses therefor
AU7684896A (en) Fas ligand fusion protein
IL128770A0 (en) A method fo preparing a plasma containing protein
AU2131195A (en) Prophenins - antibiotic peptides
AU5648196A (en) Modified polypeptides for enhanced immunogenicity
AU3873295A (en) Wood-based form parts and a method for the preparation thereof
AU5902398A (en) Cortistatin polypeptides
AU7871698A (en) Hepatitis delta particle containing a fusion protein immunogen
AU4791097A (en) Bonding materials
AU2172097A (en) Infusion packages and methods for their manufacture
AU2803595A (en) Immunodominant polypeptides
AU3966995A (en) Peptides for detection of hepatitis c antibodies